Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin to Skin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT03440736
What this trial is testing

Comparison of Secukinumab 300 mg Combined With a Lifestyle Intervention to Secukinumab Alone for the Treatment of Moderate to Severe Psoriasis Patients With Concomitant Metabolic Syndrome

Who this might be right for
PsoriasisMetabolic Syndrome
Novartis Pharmaceuticals 781
Post-approval studies (Phase 4)Study completedNCT01016977
What this trial is testing

A Phase 4, Single-Blind, Randomized, Study to Compare the Tolerability and Efficacy of 0.1% Tazorac Cream When Used in Combination With Either Duac Gel or Acanya Gel for the Treatment of Facial Acne Vulgaris

Who this might be right for
Acne Vulgaris
Stiefel, a GSK Company 40
Testing effectiveness (Phase 2)Study completedNCT04643457
What this trial is testing

Test the Safety, Pharmacokinetics, and Efficacy of UCB9741 in Healthy Study Participants and in Study Participants With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
UCB Biopharma SRL 107
Not applicableLooking for participantsNCT07562230
What this trial is testing

Rapid Construction of Tissue-engineered Skin for Repairing Difficult-to-heal Wounds

Who this might be right for
Wounds and Injuries / Mortality
First Affiliated Hospital, Sun Yat-Sen University 1,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06487000
What this trial is testing

Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Enzychem Lifesciences Corporation 150
Early research (Phase 1)UnknownNCT00916292
What this trial is testing

Safety Study of Topical Human FGF-1 for Wound Healing

Who this might be right for
Diabetic Foot Ulcers
Phage Pharmaceuticals, Inc. 8
Not applicableLooking for participantsNCT07636044
What this trial is testing

Reduced Vaccine Response to HZ/su in SLE

Who this might be right for
Vaccine ReactionZosterSystemic Lupus Erythematosus
Seoul National University Hospital 80
Early research (Phase 1)Ended earlyNCT05231668
What this trial is testing

Single Ascending Dose Study of SAR439459 in Adults With Osteogenesis Imperfecta (OI)

Who this might be right for
Osteogenesis Imperfecta
Sanofi 16
Large-scale testing (Phase 3)Study completedNCT05142774
What this trial is testing

Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Organon and Co 728
Large-scale testing (Phase 3)Study completedNCT02065713
What this trial is testing

Efficacy of Golimumab in Combination With Methotrexate (MTX) Versus MTX Monotherapy, in Improving Dactylitis, in MTX naïve Psoriatic Arthritis Patients

Who this might be right for
Psoriatic Arthritis
Instituto de Medicina Molecular João Lobo Antunes 44
Not applicableStudy completedNCT03103360
What this trial is testing

Pupillary Pain Index and Reaction to Skin Incision

Who this might be right for
PainAnesthesiaSurgery
Pr Isabelle CONSTANT 53
Testing effectiveness (Phase 2)Study completedNCT01636882
What this trial is testing

CAVATAK in Patients With Stage IIIc or IV Malignant Melanoma to Extend Dosing to 48 Weeks (VLA-008 CALM Ext)

Who this might be right for
Melanoma
Viralytics 16
Testing effectiveness (Phase 2)Ended earlyNCT00904423
What this trial is testing

Ph I/II of Vitamin D on Bone Mineral Density & Markers of Bone Resorption

Who this might be right for
Breast CancerBone Diseases
Mark Pegram 8
Not applicableStudy completedNCT01140659
What this trial is testing

Objective Evaluation of Patients With Palmar Hyperhidrosis Submitted to Two Levels of Sympathectomy: T3 and T4.

Who this might be right for
HyperhidrosisQuality of Life
University of Sao Paulo 40
Not applicableLooking for participantsNCT06282796
What this trial is testing

Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

Who this might be right for
Breast Cancer
First Hospital of China Medical University 600
Large-scale testing (Phase 3)Study completedNCT03626688
What this trial is testing

A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

Who this might be right for
PAHPulmonary HypertensionPulmonary Arterial Hypertension+8 more
United Therapeutics 687
Testing effectiveness (Phase 2)Study completedNCT01205503
What this trial is testing

Trial of Mesna to Prevent Doxorubicin-induced Plasma Protein Oxidation and Tumor Necrosis Factor Alpha (TNF-α) Release

Who this might be right for
Breast CancerNon-Hodgkin's Lymphoma
Mara Chambers 32
Early research (Phase 1)Study completedNCT03798561
What this trial is testing

Study to Evaluate ASN008 Topical Gel (TG)

Who this might be right for
Dermatitis, AtopicPruritusDermatitis Eczema
Asana BioSciences 24
Large-scale testing (Phase 3)UnknownNCT06383468
What this trial is testing

A Phase III Study to Evaluate the Efficacy and Safety of AK120 in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Akeso 420
Testing effectiveness (Phase 2)Looking for participantsNCT06254690
What this trial is testing

The Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase II Clinical Study

Who this might be right for
Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 102
Next Page